Mitsubishi and X-Body partnered to identify therapeutic target epitopes for undisclosed diseases and to develop monospecific and bispecific antibodies against the targets

X-Body BioSciences Inc.

U.S. / Private Biopharma

Licensor

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Mitsubishi Tanabe Pharma Corp.

Japan / Mid-Cap Biopharma ($1-$50 billion)

Licensee

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Active

Sample

01/01/2009

announced